San Jose, United States
Mendel.ai is an AI startup revolutionizing clinical research by leveraging machine precision and human intuition. It offers a unique clinical AI platform that enhances clinical data workflows through clinical reasoning. Powered by large language models and a clinical Hypergraph, Mendel's AI copilots, known as Hypercubes, provide reliable and explainable insights, simplifying tasks such as cohort building, chart review, and data discovery. With a focus on biopharma, providers, and diagnostics, it seamlessly integrates with existing tools and has a track record of delivering proven results.
Founded in 2017 and headquartered in the United States, Mendel.ai recently secured a $40.00M Series B investment on March 25, 2022, with backing from prominent investors including Doll Capital Management and Oak HC/FT. The company's dedication to excellence, authenticity, and innovation positions it as a key player in the intersection of AI, analytics, healthcare, and life sciences.
For more information about Mendel.ai's mission, values, and accomplishments, visitors can explore the company's website at mendel.ai.
